![](/img/cover-not-exists.png)
A phase 2 double-blinded, placebo-controlled trial of toll-like receptor 7,8,9 antagonist, IMO-8400, in dermatomyositis
Kim, Yoo Jung, Schiopu, Elena, Dankó, Katalin, Mozaffar, Tahseen, Chunduru, Srinivas, Lees, Kirstin, Goyal, Namita, Sarazin, Jeffrey, Fiorentino, David F., Sarin, Kavita Y.Journal:
Journal of the American Academy of Dermatology
DOI:
10.1016/j.jaad.2020.07.122
Date:
August, 2020
File:
PDF, 1010 KB
2020